Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanisms of HA35 on Muscle Protein Homeostasis in Healthy Controls
NCT05025865Phase 1Recruiting
- Sponsor
- Cleveland Clinic
- Start
- Feb 2022
- Primary completion
- Oct 2028
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised trial of sodium hyaluronate (2 arms), sponsored by Cleveland Clinic. Primary endpoints: Aspartate Aminotransferase at Day 4 and Alanine Aminotransferase at Day 4. Started Feb 2022; status: recruiting.
02
Drugs
sodium hyaluronate
Beyond the preview
Go deeper on NCT05025865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05025865.